학술논문

SO-20 Prospective validation of Ang-2 and Tie-2 plasma levels as predictors of benefit from regorafenib in metastatic colorectal cancer patients: REGOLAND study
Document Type
Abstract
Source
In Annals of Oncology July 2021 32 Supplement 3:S211-S211
Subject
Language
ISSN
0923-7534